By leveraging berberine's documented ability to influence cellular energy regulation and glucose metabolism, this botanical product is positioned as an accessible, scientifically backed holistic alternative to naturally manage blood sugar levels and support sustainable wellness without relying solely on synthetic pharmaceuticals In December 2025, Innovent Biologics, a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic, ophthalmologic and other major diseases, announces that the results of two Phase III clinical studies of Mazdutide, the world's first approved glucagon (GCG)/glucagon-like peptide-1 (GLP-1) dual receptor agonist, in Chinese adults with type 2 diabetes (T2D) (DREAMS-1, DREAMS-2) have been published back-to-back in Nature as Accelerated Article Previews (AAP)

2 Billion AFU for Higher Potency and Optimal Benefits: Harness the full potential of our refined formula, featuring 2 billion active colony-forming units (AFU) to deliver exceptional potency
Despite this short half-life, its effects persist due to its ability to stimulate long-lasting cellular responses
Allowed to stand for 20 minutes at room temperature and after 20 minutes, collected the upper aqueous layer for injection